PeptideStack
5.2kquestions
20kanswers
220users

Is retatrutide at 2 mg/mL stable enough for sixteen weeks of multi-withdrawal use?

Asked 19 Apr 2026Modified 1 min agoViewed 10k times
This question was closed as primarily opinion-based.Closed 28 Apr 2026. Answers already posted are preserved; new answers are not accepted. Questions here need a factual basis on which they can be answered.
19

Stated plainly: retatrutide · 2 mg/mL · sixteen weeks.

This is asserted often enough that I assumed it was established, and then I went looking for the source.

I have searched the primary literature and found one paper that is adjacent but not on point.

Can anyone point me at a primary source, or confirm that there is not one?

peptide-stability
peptide-stability

The chemistry of peptide degradation: deamidation, oxidation, hydrolysis, aggregation and fibrillation, and how temperature, pH, ionic strength,…

908 questions
bacteriostatic-water
bacteriostatic-water

Water for injection containing roughly 0.9 per cent benzyl alcohol as a bacteriostatic agent. It suppresses growth in a multiple-withdrawal vial;…

149 questions
shelf-life
shelf-life

How long a preparation remains within specification: labelled expiry for a sealed lyophilised vial, beyond-use dating after reconstitution, and…

327 questions
retatrutide
retatrutide

An investigational GLP-1, GIP and glucagon receptor tri-agonist, studied in the TRIUMPH programme. Not approved anywhere. Use this tag for…

251 questions
shareeditfollowflag
MI
askedmateo_iglesias12k1619 Apr 2026
Same situation here, so I will follow this one. – micron22 2 months ago
2Is the material lyophilised or already in solution? Completely different answer. – Dr_Rosalind_Achebe 4 months ago
add a comment

5 Answers

Accepted answer first, then by votes
43

Accepted answer

sixteen weeks is 112 days and, on a weekly schedule, 16 stopper punctures out of one vial at 2 mg/mL. Set the chemical question aside for a moment, because the puncture count is the one with a convention attached: 112 days is 4 times the twenty-eight days conventionally allowed for a preserved multi-dose preparation once it has been entered. Chemically, 2 mg/mL is high enough that adsorption to the glass is a rounding error and low enough that it is not protecting you from anything. What 16 withdrawals do add is 16 opportunities to introduce air, 16 coring events on the same stopper, and a headspace that grows with every draw — none of which show up on a certificate and all of which are avoided by splitting into aliquots at reconstitution.

This is answerable from the chemistry rather than from anecdote, which is unusual and welcome.

Aggregation is physical: peptides unfold at air-liquid interfaces and associate. Shaking maximises that interface, which is why swirling and shaking produce visibly different outcomes on the same vial.

Concretely, deamidation converts asparagine or glutamine to the corresponding acid via a succinimide intermediate, adding one dalton. It is base-catalysed, accelerates above neutral pH and is the dominant aqueous pathway for many peptides.

Aggregation at air-liquid interfaces is established from surface-tension and particle-count studies and is the basis for anti-agitation handling guidance.

Swirl, never shake. Aggregation is a handling problem more than a time problem.

edited 14 Aug 2026 by laminar_bench — added a caveat about sampling

shareimprove this answerflag
LB
answered · acceptedlaminar_bench69k5720 Jul 2026
Sponsored

Janoshik Analytical - Independent Third-Party Testing

HPLC purity, identity confirmation and quantified content on the vial you actually hold. Reports arrive with the chromatogram attached, not just a number.

Submit a sample
Sponsored — paired listing

GL Biochem (Shanghai) Ltd. - Direct Synthesis

Founded 1998. ISO 9001 and cGMP certified, 1,500+ staff and 200+ patents. The synthesis house behind a great many of the vials that get sent out for testing - batch-specific documentation with every order.

Visit GL Biochem
45

The honest answer is that most reported "degradation" is adsorption and dilution error rather than chemistry.

Oxidation targets methionine, cysteine and tryptophan, adding sixteen daltons per oxygen. It is catalysed by trace metals and promoted by dissolved oxygen and by light.

Stated carefully, adsorption onto glass and plastic is significant at low concentrations — micrograms per millilitre — and negligible at milligrams per millilitre. It is the usual explanation for an apparent loss in a dilute preparation.

At dilute concentrations, suspect adsorption before you suspect chemistry.

shareimprove this answerflag
TQ
answeredtriple_agonist_q57k384 Jun 2026
30

Start with the sequence, because which pathways are available depends on which residues are present.

Freeze-thaw cycling drives aggregation through concentration at the ice interface and pH shifts as buffer components crystallise out at different rates. Each cycle costs something.

A mass spectrum resolves most of this: minus eighteen is dehydration or succinimide, plus one is deamidation, plus sixteen is oxidation, and an unchanged mass with a shifted retention time is an isomer.

Nothing here is medical advice, and research-use compounds are not approved for human use.

A mass spectrum names the pathway. Plus one, plus sixteen, minus eighteen.

shareimprove this answerflag
BF
answeredbea_forsberg11k1727 Jun 2026
19

Answer first: the degradation pathways worth knowing are hydrolysis, deamidation, oxidation, aggregation and adsorption, and each has a different trigger and a different mitigation.

Hydrolysis cleaves the backbone, most readily at aspartate-proline and aspartate-glycine sequences, and is acid-catalysed. In a dry solid it barely proceeds at all.

Apparent loss in a dilute preparation is usually adsorption rather than degradation and is worth ruling out first.

Cold, dry, dark, still. Those four words cover most of the mitigation.

shareimprove this answerflag
LM
answeredleonid_marchuk19k272 May 2026
I have kept vials both ways for a year and this matches what I saw. – esther_vandeVelde 44 days ago
add a comment
14

The relevant detail is that asparagine and glutamine are the deamidation risk, and methionine is the oxidation risk.

Light exposure matters for tryptophan-containing sequences and for anything with a chromophore. Amber vials and a closed box are free mitigations.

Sequence decides which pathways are even available. Check the residues.

shareimprove this answerflag
HL
answeredharriet_lonsdale35k13826 May 2026
4Small correction: it is the number of cycles rather than the freezer temperature that does the damage. – Dr_Rosalind_Achebe 9 months ago
5Adding for future readers: the domestic leg after delivery is the part you control. – Dr_Ingrid_Baumgartner 26 days ago
add a comment

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.